Julie Tompkins, MBA, is Sr. Vice President at Timely Data Resources (TDR), a healthcare market research and consulting firm. She has more than 30 years experience in the pharmaceutical and biotech arenas, including more than 12 years in industry and nearly 21 years in market research consulting, and has worked with pharmaceuticals, diagnostics, and drug delivery systems. At Syntex (now Roche), Julie worked in both R&D and Marketing, including positions as Analytical Chemist, Market Research Analyst, Manager of New Product Planning, and Manager of Market Analysis. She spent most of her time in Marketing as the primary liaison between Marketing and R&D, serving as a key member on multi-disciplinary project teams and strategic planning committees. After leaving Syntex, Julie was President and Founder of MedSearch, a primary market research company that merged with TDR in January 2000. She holds a B.A. in Human Biology from Stanford University and an MBA from Santa Clara University.
In the past few decades, patients’ roles in treatment choices have increased as never before, and the shared decision making process has changed more than the way patients and physicians interact. The availability of information on the Internet along with the advent of direct-to-consumer prescription drug advertising has greatly increased the ability of individuals to research their own health conditions and treatment options, and to become more informed consumers. Julie will discuss how patients’ active roles in choosing and staying on medications can impact both drug development and marketing programs, including why and how manufacturers are including input from patients along with that from physicians, insurers, and other decision makers.
